Key Takeaways
- Resilient quarter, margin floor called: EBITDA margin rebounded to ~6.2% and management explicitly stated it has bottomed out, with GenX revenue ramp-up the primary lever for improvement from here.
- GenX is the margin story: The new business is already offsetting ₹30–₹40 crore of its quarterly fixed cost, and management expects PBT breakeven within 12 months on visibility of ₹500–₹600 crore turnover over a period of next 12 months.
- CBG gets structural push: A new GOBARdhan policy, a ₹100 crore JV with BPCL, and proven multi-feedstock technology position Praj to capture a TAM measured in thousands of crores, though ecosystem build-out will take years.
- Ethanol feedstock shift underway: OMCs excluded sugary feedstocks from new procurement tenders, accelerating the move toward grain-based and C-Heavy molasses plants, a transition where Praj’s retrofit capability becomes a differentiator.
- What to watch next quarter: Whether GenX order booking ramps in H2 as guided, the pace of CBG JV project finalization, and any clarity on the fate of greenfield projects stuck on sugary feedstock challenges.
GenX: The Margin Recovery Engine
- Revenue already flowing: GenX revenue is being accounted for and offsets roughly ₹30–₹40 crore of the quarterly fixed-cost burden of ~₹45 crore (₹25–₹30 crore operational plus ₹15–₹20 crore interest and depreciation, the latter driven largely by Ind AS lease accounting on a 10-year lease now three years in).
- Order book building: A data center order from the existing ~$52 million customer relationship was booked in Q2, covering precision-fabricated server-hosting frames and complex cooling-system piping for hyperscalers; management called the opportunity with this single customer "fairly significant" and confirmed engagement with new customers as well.
- Customer approvals scaling: The Mangaluru facility now has 18 international customer approvals and 4 operationalized framework agreements, creating the base for order conversion.
- H2 ramp-up expected: Management expects to be "absolutely right" on previously indicated FY27 order booking numbers, with orders trickling from Q3 and revenue hitting the top line from Q4 onward; some orders are fast-track, others carry longer delivery cycles.
- Breakeven in sight: On current and expected H2 order inflows, management assured PBT breakeven within the next 12 months, with visibility to deliver ₹500–₹600 crore of turnover over that period; the exact breakeven revenue depends on the mix of equipment, modules, and data center work.
- Cost structure is now variable: If execution ramp-up in Q3/Q4 requires additional sheds, any incremental cost brings corresponding revenue, so management views it as variable rather than a fixed-cost drag.
Sachin Raole: "That's right, Atul. We can say that." (confirming margins have bottomed out at ~6.2% and unlikely to fall below)
CBG: Policy Tailwind Meets Proven Technology
- GOBARdhan policy catalyst: The new policy has created strong market interest, with inquiry pipeline growth across Napier grass, rice straw, and press mud-based CBG plants; assured offtake pricing by OMCs and GAIL makes project economics attractive even without co-product revenue.
- BPCL JV formalized: The board gave in-principle approval to invest up to ₹100 crore in a 50/50 JV with BPCL; incorporation is expected in 2–3 months, projects are already shortlisted, and ordering opportunity could materialize over the next 12 months, with 8–10 plants targeted over 3 years.
- Technology credibility is the moat: One Praj customer plant won "Best Operated Plant of the Year," and another produced 5,000 tons of CBG in 500 days, demonstrating consistent production; management emphasized that while many players flocked to the opportunity, credible technology is what differentiates.
- Multi-feedstock advantage: Praj plants can process multiple feedstock types through the same asset, enabling round-the-year operation; the JV plants will pursue the same strategy, with bio-bitumen as an additional co-product when using rice straw or Napier grass, improving ROI versus single-feedstock competitors.
- TAM is vast, realization is slow: Management pegs the CBG addressable market in thousands of crores over 5–10 years, but ecosystem development (feedstock availability, pipeline infrastructure, plant success demonstrations) means realization will take time over several years.
Ashish Gaikwad: "while there were many players who flocked into this opportunity, it is important to have credibility on technology, and that's what Praj brings in."
Ethanol: Feedstock Shift Creates Retooling Demand
- OMC tender resets the feedstock map: State-run OMCs excluded sugarcane juice, sugar syrup, and B-Heavy molasses from recent ethanol procurement tenders for the 2026-27 supply year, permitting only C-Heavy molasses and approved grains (maize, broken rice).
- Brownfield retrofit demand rising: Order booking was a mix of a few greenfield and mostly brownfield solutions, with customers prioritizing operational efficiency improvements and value-added co-products like distillers corn oil to improve plant profitability.
- Feedstock-switching flexibility in demand: Several customers are interested in adding grain modules as an add-on to sugar-based plants, enabling switching based on market conditions, availability, and profitability.
- Greenfield backlog stuck: Customers continue to face project funding challenges, and the ethanol supply-demand imbalance has slowed backlog conversion to revenue; projects based on sugary feedstocks face particular challenges, with management expecting clarity by the end of this financial year.
- E100 legally recognized: The Ministry of Road Transport and Highways amended the Central Motor Vehicles Rules 1989 to legally recognize E100 (100% ethanol) as fuel for certified flex-fuel vehicles, a policy step that expands the long-term demand canvas.
Ashish Gaikwad: "As Indian ethanol producers face such feedstock variation challenges, Praj provides them the required operational flexibility with our proven design, decades of experience, and end-to-end solution and services to deal with this situation."
International & Emerging Verticals
- International pipeline building: Parts of international markets are developing positively across the USA, Brazil, Argentina, Southeast Asia, and Africa, driven by rising ethanol blending mandates and energy self-sufficiency goals; an opportunity pipeline of roughly ₹1,000 crore is developing over the next few quarters, with bioenergy as the primary vertical.
- SAF milestone approaching: Delivery of the detailed engineering package for an ethanol-to-SAF plant for an international customer is progressing well; the final investment decision is expected in Q1 FY28, and a favorable FID will create opportunities to supply equipment and modules.
- Bio-isobutanol nears demonstration: Technology developed over several years is approaching commercialization, with scale-up demonstration expected by the beginning of next year; government agencies are parallelly testing blending proportions in diesel vehicles, though policy and blending mandates remain outside Praj's control.
- Lifecycle services compounding: The business continues to grow steadily quarter-over-quarter, serving the installed base globally and domestically beyond project delivery.
Ashish Gaikwad: "Overall, we remain optimistic, but we don't control the policy, or we don't control the blending mandate. So, we are, therefore, one of the several stakeholders in seeing to it that we get a biofuel which is viable and which can be blended into diesel, because diesel is a large market in India."
Margin Structure & Cost Dynamics
- Current margin floor: EBITDA margins have rebounded from very low levels but remain below FY24/FY25 levels; management stated current levels (~6.2%) are bottomed out and unlikely to fall below this level going forward, with GenX revenue ramp-up and overall revenue improvement expected to drive recovery.
- GenX is the drag and the cure: Investment in GenX continues to weigh on margins while revenue numbers remain low relative to expectations; the same business is the primary lever for margin improvement as order booking and revenue ramp up in H2 and beyond.
- Data center order quantum undisclosed: Management declined to quantify the Q2 data center order inflow, citing a "very tight confidentiality agreement" with the customer.
The ₹10,000 Crore Vision: Delayed, Not Derailed
- Ambition reaffirmed: Management restated the ₹10,000 crore revenue vision by 2030, acknowledging that some assumed inflection points have been delayed but not canceled; new strategies including GenX data centers, international markets, CBG, and Bio-IBA are expected to compensate for the delays.
- CBG JV capacity question: An investor asked why BPCL would partner with other technology players when Praj offers unique multi-feedstock and bio-bitumen capabilities; management speculated that BPCL may want to run multiple JVs in parallel to achieve a larger number of plants in a short span, and one JV's finite capacity may not suffice.
Ashish Gaikwad: "What has happened, though, is some of the inflection points that we have assumed in our journey have been delayed. Those are not something that have got canceled, but those are delayed... our direction and our ambition remains steadfast."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| GenX order booking | Management expects to be "absolutely right" on previously indicated FY27 numbers; orders to trickle from Q3 | H2 FY27 |
| GenX PBT breakeven | Breakeven on visibility of ₹500–₹600 crore turnover | Within next 12 months |
| GenX revenue on top line | Revenue effect visible | Q4 FY27 and onwards |
| EBITDA margin floor | Margins bottomed out at ~6.2%, unlikely to fall below | Current levels onward |
| CBG JV incorporation | 50/50 JV with BPCL incorporated | Next 2–3 months |
| CBG JV first plant | Commercial production after ~15 months; 8–10 plants over 2–3 years | ~15 months from JV incorporation |
| CBG JV ordering opportunity | Ordering from JV could materialize | Over next 12 months |
| Greenfield backlog clarity | Clarity on projects facing sugary-feedstock challenges | By end of FY27 |
| Bio-IBA scale-up demonstration | Commercialization and scale-up demonstration | Beginning of next year |
| SAF final investment decision | Customer FID expected | Q1 FY28 |
| International pipeline | Opportunity pipeline of ~₹1,000 crore developing | Over next few quarters |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Consolidated income from operations | ₹849 crore, compared to ₹842 crore in Q2 FY26 |
| Profit before tax | ₹36.1 crore, compared to ₹29.6 crore in Q2 FY26 |
| Profit after tax | ₹23.1 crore, compared to ₹19.2 crore in Q2 FY26 |
| H1 FY27 income from operations | ₹1,560 crore, compared to ₹1,480 crore in H1 FY26 |
| H1 FY27 profit after tax | ₹34.7 crore, compared to ₹24.62 crore in H1 FY26 |
| EBITDA margin | ~6.2% (per an analyst's math) |
| Export revenue share | 38% of total revenue |
| Revenue mix | 69% Bioenergy, 21% Engineering, 10% PHS |
| Order intake | ₹715 crore, 62% domestic and 38% international |
| Order intake mix | 57% bioenergy, 26% engineering, 17% PHS |
| Order backlog | ₹4,460 crore as of September 2026, 63% domestic |
| Cash in hand | ₹533 crore as of September 30, 2026 |
| International opportunity pipeline | ~₹1,000 crore developing over next few quarters, mainly bioenergy |
| GenX facility customer approvals | 18 international customers approved, 4 framework agreements operationalized |
| GenX data center tie-up | $52 million to be delivered over approximately 2.5 years |